Why are these stocks considered cheap?

They trade at low P/E ratios (single-digit or low double-digit) despite strong cash flows and earnings growth, due to investor neglect of the healthcare sector.

Does the report give a buy recommendation?

No, the report does not provide a buy recommendation; it only suggests these stocks may be undervalued and encourages investors to do their own research.

3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

According to 24/7 Wall St., healthcare stocks are unloved in 2026, creating a rare value opportunity. Three stocks under $30 offer strong fundamentals: Johnson & Johnson, Pfizer, and a third unnamed stock.

July 7, 2026

2 min read

Source: 24/7 Wall St.

According to a report by 24/7 Wall St., the healthcare sector has been neglected by investors in 2026, creating a rare opportunity to buy quality names at depressed prices. The report identifies three stocks trading under $30 with strong value characteristics.

The Three Stocks Under $30

1. Johnson & Johnson (JNJ)

Price: Under $30 (post-split)
P/E Ratio: Single-digit
Highlights: Strong dividend, diversified portfolio, stable guidance.

2. Pfizer (PFE)

Price: Under $30
P/E Ratio: Low double-digit
Highlights: Strong cash flow, earnings growth despite COVID revenue decline.

3. Third Stock (name not disclosed in summary)

Price: Under $30
Highlights: Growing earnings, attractive valuation.

Why Are These Stocks Cheap?

The sector suffers from investor apathy due to regulatory uncertainty and post-pandemic growth slowdown. However, these companies continue to generate profits and dividends, making them value plays.

What Does This Mean for Investors?

The report does not provide a buy recommendation but suggests these stocks may be undervalued. Investors should conduct their own research and consider risks such as regulatory changes and competition.

Frequently Asked Questions

The report highlights three stocks: Johnson & Johnson (JNJ), Pfizer (PFE), and a third unnamed stock, all trading under $30.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.